CAPITAL4 NEWS

 

  • NIFTY4,860.5  
  • -45.6 -0.9%
  • SENSEX16,026.4  
  • -156.9 -1.0%

Strides Arcolab sells its generic pharmaceuticals operations in Australia & Southeast Asia to Watson Pharmaceuticals

Source: Capital Market, Tuesday, January 24th, 02:49 PM

Strides Arcolab has announced the sale of its 94% shareholding in Ascent Pharmahealth, its subsidiary with operations in Australia and Southeast Asia to Watson Pharmaceuticals, Inc. As part of the transaction, Watson also acquired the remaining 6% shareholding associated with Dennis Bastas, CEO of Ascent. The transaction was signed and closed simultaneously. The cash offer from Watson values Ascent at an enterprise value of AU$ 375 million.

TOP BLOGS

View all blogs